Case 1:07-cv-00432-GMS
Document 32
Filed 07/11/2008
Page 1 of 2
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, DR. KARL THOMAE GMBH, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, and BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Plaintiffs, v. BARR LABORATORIES, INC., Defendant.
C. A. No. 07-432-GMS
FINAL JOINT CLAIM CHART The parties have met and conferred, and present the following Final Joint Claim Chart with citations to intrinsic support pursuant to the Scheduling Order entered by the Court on January 11, 2008 (D.I. 17-2), as amended on May 14, 2008 (D.I. 29). The parties' Final Joint Claim Chart for U.S. Patent No. 6,015,577 is attached hereto as Exhibit A. This chart identifies the disputed claim terms, the parties' proposed constructions for the disputed claim terms, and the parties' identifications of the intrinsic evidence in support of their respective proposed constructions.
Case 1:07-cv-00432-GMS
Document 32
Filed 07/11/2008
Page 2 of 2
MORRIS, NICHOLS, ARSHT & TUNNELL LLP
PHILLIPS, GOLDMAN & SPENCE, P.A.
/s/ Karen Jacobs Louden
Jack B. Blumenfeld (#1014) Karen Jacobs Louden (#2881) 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899-1347 (302) 658-9200 [email protected] [email protected]
/s/ Brian E. Farnan
John C. Phillips, Jr. (#110) Brian E. Farnan (#4089) 1200 North Broom Street Wilmington, DE 19806 (302) 655-4200 [email protected] [email protected]
OF COUNSEL: OF COUNSEL: Bruce M. Wexler Joseph M. O'Malley, Jr. Eric W. Dittmann PAUL, HASTINGS, JANOFSKY & WALKER LLP 75 East 55th Street New York, NY 10022 (212) 318-6000 Attorneys for Plaintiffs Dated: July 11, 2008
2407900
George C. Lombardi Imron T. Aly Timothy M. Schaum WINSTON & STRAWN LLP 35 West Wacker Drive Chicago, IL 60601 (312) 558-5600 Attorneys for Defendant
2
Case 1:07-cv-00432-GMS
Document 32-2
Filed 07/11/2008
Page 1 of 3
EXHIBIT A
Case 1:07-cv-00432-GMS
Document 32-2
Filed 07/11/2008
Page 2 of 3
Boehringer Ingelheim et al. v. Barr Laboratories, Inc. (Case No. 07-432-GMS) FINAL JOINT CLAIM CHART U.S. Patent No. 6,015,577 Boehringer Ingelheim's Proposed Construction the acid excipient is present with the first component in a single formulation Boehringer Ingelheim's Intrinsic Evidence '577 Patent, Col. 2:53-3:65; 4:38-5:11; 5:23-31; 9:63-13:16; 14:7-34 '577 Prosecution History Original Application 07/084,648 Application 08/421,351 Barr's Proposed Construction a pharmaceutically acceptable acid excipient mixed with said first component Barr's Intrinsic Evidence Claims 1, 2, 7, 8, 9, 10, 15 '577 Patent, Col. 2:1-3:65; 4:29-5:11; 9:63-13:17 '577 Prosecution History Original Application 07/084,648 Application 08/421,351 2-15-96 Response to Office Action 3-12-96 Response to Office Action 6-13-96 Office Action 9-9-96 Response to Office Action 11-5-96 Response to Office Action 12-4-98 Response to Office Action
Claim Term "a pharmaceutically acceptable acid excipient formulated together with said first component" (Claims 1-12)
-1-
Case 1:07-cv-00432-GMS
Document 32-2
Filed 07/11/2008
Page 3 of 3
Boehringer Ingelheim et al. v. Barr Laboratories, Inc. (Case No. 07-432-GMS) FINAL JOINT CLAIM CHART Claim Term "inhibiting" (Claims 16-20) Boehringer Ingelheim's Proposed Construction reducing compared to what would otherwise be but for the method employed Boehringer Ingelheim's Intrinsic Evidence '577 Patent, Col. 6:35-56; Figures 2-6; 7:35-50; 9:42-50 '577 Prosecution History Original Application 07/084,648 Application 08/421,351 Response to Office Action, dated February 15, 1996 Office Action of June 13, 1996 Response to Final Office Action, dated September 9, 1996 Office Action of March 23, 1999 Response to Office Action, dated March 29, 1999 Barr's Proposed Construction The term is indefinite Barr's Intrinsic Evidence Claims 16-20 '577 Patent, Figures 1-11; Col. 1:28-53; 2:30-52; 5:329:61; 9:63-13:17 '577 Prosecution History Original Application 07/084,648 Application 08/421,351 2-15-96 Response to Office Action 3-12-96 Response to Office Action 6-13-96 Office Action 9-9-96 Response to Office Action 11-5-96 Response to Office Action 11-12-98 Examiner Interview Summary 12-4-98 Response to Office Action 3-23-99 Office Action 3-29-99 Response to Office Action
-2-